Navigation Links
Excalibur - 'Transforming' Biotech Deals can Still be Achieved
Date:10/1/2008

LONDON, October 1 /PRNewswire/ -- Excalibur, the international investment house specialising in medical sciences, said today 'transforming' deals could still be achieved in the UK biotech sector despite the most severe market conditions.

Excalibur, founded by Professor Sir Christopher Evans and a development of Merlin Biosciences, was instrumental in securing important funding to enable York Pharma plc, the specialist dermatology company, to make a significant product acquisition which will propel the company into profit and generate significant revenues.

Following York Pharma's announcement today (Wednesday) that it has completed the EUR28.5 million financing package to fund the acquisition, Professor Sir Christopher Evans, chairman of Excalibur, said: "This is exactly what everyone wants to see in the UK biotech sector, where a loss-making company can be turned into a revenue generating and profitable operation offering products to the market.

"Excalibur was delighted to assist York Pharma through an investment by Merlin Biosciences Fund III while the company secured additional funding from the United States. While it is extremely reassuring that investment funding is still available from the USA, it is important in the UK biotech sector to show that such transforming deals can be achieved despite the grim economic picture."

York Pharma has acquired the sales and worldwide commercial rights to two dermatological/wound care products, Flammazine and Flammacerium, from Solvay Pharmaceuticals. The products are sold in 21 countries and are used in the prevention and treatment of infections in burn wounds and tropical wounds. The products generate annual revenues of GBP8.5 million.

Sir Christopher commented: "Last year York Pharma acquired a Merlin Biosciences Fund III company, Derms Developments, which gave it a sales, marketing and product offering. This deal now means the company can take another important step forward and we
'/>"/>

SOURCE Excalibur
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Excalibur Celebrates PIramed Sale With Substantial Cash Return to Investors
2. SkyeTek to Present Webinar on Transforming the Management of Medical Devices & Supplies with Embedded RFID
3. BioSpace and BIOCOM Announce 2009 Biotech Beach(TM) Hotbed Campaign
4. Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent
5. Jacobs Receives Contract From Gedeon Richter for New Biotechnology Facility in Hungary
6. InNexus Biotechnology CEO to Present at BioContactQuebec 2008
7. Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals
8. Alexions Soliris(R) Receives 2008 Prix Galien USA Award for Best Biotechnology Product
9. Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
10. New Report on 633 Biotechnology Medicines Under Development Released in Michigan
11. Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...TY,Calif.,Nov.24/PRNewswire-FirstCall/--GenomicHea...t,GenomicHealth,sExecutiveChairman,willpresentatth...rkCityonTuesday,December1,2009at10:00a.m.ET. ,,...epresentation,visittheInvestorRelationssectionofGe...th.com .Pleaseconnecttothewebsiteatleast15minutesp...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the glo...hina,s patent office is now the world,s leading pr...ry. China trailed Japan,s patent office, the World...e United States Patent and Trademark Office (USPTO...2005, WIPO in 2006, and exceeded Japan for the fir...
(Date:11/23/2009)... You can think of it as origami very high-tech o...is have developed a technique for fabricating thre...es from thin films by coupling photolithography an...actions. , The films, only a few microns thick, o...ith thicker pieces of the same material. , "This ...
(Date:11/23/2009)...LLAGE,Nev.,Nov.23/PRNewswire-FirstCall/--PDLBioPha...AQhasestablishedNovember27,2009astheex-dividenddat...ultingfromthesecuritizationtransactioncompletedonN...09toallstockholdersofrecordontherecorddate,Decembe...thedividendat$1.67pershareofcommonstockforpurposes...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Water droplets direct self-assembly process in thin-film materials 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...wswire-Asia-FirstCall/ -- China,Biologic Products,... or the,"Company"), one of the leading plasma-base...c of China ("PRC"), today announced that one of it...ill be listed in the National Torch,Plan of China....xecuted in 1988, by China,s,Ministry of Science an...
...ire-Asia-FirstCall/ -- Shengtai,Pharmaceutical, In...Company"),a leading manufacturer and distributor o...cts in China, today reported financial results for...31, 2008. , "Sales of our glucose products inc... September quarter," said Mr. Qingtai Liu, Shengta...
...ogies announces the launch of its new informative ...interactive e-book designed to introduce the gener...ying biotechnologies behind the clinical developme...ly targeted, genetic medicine that has been valida...Genetics, 2007), Rexin-G is designed to seek-out a...
Other Biology Technology:China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan 2China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan 3Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 2Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 3Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 4Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 5Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 6Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 7Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 8Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 9Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 10Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 11Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial 2
(Date:11/23/2009)...research presents strong evidence that the "synerg...or traffic-related pollution and indoor endotoxin ...he other exposure alone. , Environmental healt...College of Medicine have shown that children expos...s and indoor endotoxin during early life are six t...
(Date:11/23/2009)...ember 23, 2009 - The time of day matters to forest...per produced by a research team led by Professor M...,s vice-principal for research and colleagues in t...t. George campus. , Capitalizing on their prev... the research team examined how poplar trees use t...
(Date:11/23/2009)... Current research suggests that a common oral bac...ated report by Nichols et al, "Unique Lipids from ...TLR2 Ligands Capable of Enhancing Autoimmunity," a... Journal of Pathology . , Multiple sclerosis (MS...rain and spinal cord, affects nearly 1 in 700 peop...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2All Fifty States to Screen Newborns for Cystic Fibrosis by 2010 50906 1All Fifty States to Screen Newborns for Cystic Fibrosis by 2010 50906 2Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 1Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 2Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 3Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 4Jazz Pharmaceuticals Completes 247 Million Private Placement 50902 1Jazz Pharmaceuticals Completes 247 Million Private Placement 50902 2
...aren Beemon has been awarded the third annual Retr...eque and a crystal trophy and is interviewed in an...l Retrovirology. She is Professor and Chair of the... I am very honored to receive the 2007 Retrovirolo...e Retrovirology community. It is gratifying that t...
...selaer Polytechnic Institute have developed a new ...rous proteins such as anthrax toxin, and render th... lends itself to the creation of new antibacterial...f germs, and also holds promise for new methods of... , Scientists have long been interested in wrappi...
...rons is a hallmark of many neurodegenerative disea...ell biology and regenerative medicine offer novel ... This week in the online open-access journal PLoS ...jeshwar Awatramani, and Dr. Ronald McKay show that...le in the birth and death of dopamine neurons in t...
Other Biology News:Karen Beemon wins the 2007 Retrovirology Prize 2Using carbon nanotubes to seek and destroy anthrax toxin and other harmful proteins 2
Rabbit Anti-NMDA NR2B, phospho (Tyr1336) Polyclonal Antibody, Unconjugated from Novus Biologicals
MTT Reagent A from CHEMICON
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
PIP Strips from Echelon Biosciences Inc.
Biology Products: